Has Acclarent Been Banished from the Ethicon/Johnson & Johnson Empire?
UPDATED CafePharma Response (below)
August 21, 2014
It’s been shown here time and time again, that when a company does something wrong they will often change their name to distance themselves from unethical or illegal behavior which is a characteristic of The Sociopathic Business Model™. Once made aware of the characteristics it becomes easier to predict patterns of companies. As a refresher:
On the popular the anonymous message board CafePharma the company Acclarent (a venture capital funded startup sinus device company) purchased by Johnson & Johnson’s Ethicon in January 2010 for $785 million according to the Wall St. Journal was, up until last week, under the Ethicon heading on the board made popular by reps and disgruntled former employees.
Inexplicably the Acclarent board moved out from under Ethicon (a division of Johnson & Johnson) and under its own company heading.
It’s also interesting to note that Acclarent has less than 500 employees but the thread on the board has been viewed more than 353,559 times since the start in 2010. Who could possibly be looking at this company? What could possibly make this little company that sold for hundreds of millions to the largest producer of consumer and medical products in the World so interesting? Time will tell; and, if fact based evidence over time is any indication of the future The Wall Street Journal will be the only major news outlet covering any story about Johnson & Johnson and their subsidiaries. I’ll reach out to both CafePharma and the Wall St. Journal for comment.